Development of Nonsurfactant Cyclodextrin Nanoparticles Loaded With Anticancer Drug Paclitaxel
- 1 April 2008
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 97 (4) , 1519-1529
- https://doi.org/10.1002/jps.21111
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Amphiphilic β-Cyclodextrins Modified on the Primary Face: Synthesis, Characterization, and Evaluation of Their Potential as Novel Excipients in the Preparation of NanocapsulesJournal of Pharmaceutical Sciences, 2002
- Influence of cationic lipids on the stability and membrane properties of paclitaxel‐containing liposomesJournal of Pharmaceutical Sciences, 2001
- Molecular effects of paclitaxel: Myths and reality (a critical review)International Journal of Cancer, 1999
- Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheresJournal of Biomedical Materials Research, 1998
- Solubility and stability of taxol: effects of buffers and cyclodextrinsInternational Journal of Pharmaceutics, 1996
- Pharmaceutical and Physical Properties of Paclitaxel (Taxol †) Complexes with Cyclodextrins ‡Journal of Pharmaceutical Sciences, 1995
- Interaction of taxol and other anticancer drugs with α-cyclodextrinJournal of Pharmaceutical and Biomedical Analysis, 1995
- Interaction of taxol and other anticancer drugs with hydroxypropyl-β-cyclodextrinInternational Journal of Pharmaceutics, 1994
- Clinical pharmacokinetics of doxorubicin in hepatoma patients after a single intravenous injection of free or nanoparticle-bound anthracyclineInternational Journal of Pharmaceutics, 1989
- Tissue Distribution of Antitumor Drugs Associated with Polyalkylcyanoacrylate NanoparticlesJournal of Pharmaceutical Sciences, 1980